Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy [Phase 4]
A Phase 4 clinical trial evaluated methylphenidate for treating attention-deficit/hyperactivity disorder in children with coexisting epileps…
-
FDA approval · 2013-07-31FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Aurolife Pharma, LLC)
FDA approved Aurolife Pharma, LLC's dextroamphetamine sulfate as an original-application generic, authorizing a generic stimulant for attent…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
A Phase 4 trial evaluating the efficacy of the osmotic-release methylphenidate formulation in Attention-Deficit/Hyperactivity Disorder; resu…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder [NA]
This clinical trial update notes that the study evaluating relaxation response training with functional MRI in adults with ADHD has complete…
-
FDA approval · 2013-07-30FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) submitted by Janssen Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
This clinical trial update indicates the completion of a study evaluating organizational skills interventions for children with Attention De…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD) [NA]
This document reports the completion of a clinical trial evaluating omega-3 fatty acid supplementation for Attention Deficit Hyperactivity D…
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
A Phase 4 clinical trial update reports results for long-acting methylphenidate in adults with ADHD, including efficacy and quality-of-life …
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia [Phase 3]
Phase 3 long-term safety study of eszopiclone in children and adolescents with ADHD-associated insomnia has completed, and results were post…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Placebo-Controlled Trial With GlyTI-M Among Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]
A Phase 2, placebo-controlled trial evaluating GlyTI-M in children with ADHD has completed.
-
FDA approval · 2013-07-09FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Lannett Company, Inc.)
FDA approved the original ANDA for a generic methylphenidate hydrochloride product by Lannett Company, Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Phase 4]
Phase 4 randomized, double-blind trial comparing Concerta to placebo in adults with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate [Phase 3]
Phase 3 trial comparing lisdexamfetamine dimesylate with atomoxetine in ADHD patients with inadequate response to methylphenidate; results p…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients [Phase 2]
A completed Phase 2 trial evaluated the effectiveness of lobeline in treating symptoms of attention-deficit/hyperactivity disorder in adults…
-
FDA approval · 2013-06-14FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental NDA for a four-salt amphetamine product (dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextro…
-
FDA label_change · 2013-06-14FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse to update the product labeling.
-
FDA label_change · 2013-06-14FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for Methylin (methylphenidate hydrochloride) from Shionogi Inc., indicating a labeling change for th…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Tocotrienols for School-going Children With ADHD [Phase 2, Phase 3]
Clinical trial update indicating completion of Phase 2 and Phase 3 studies investigating tocotrienols for attention-deficit/hyperactivity di…
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Spectroscopy in Children and Adolescents With Bipolar Disorder
This completed clinical trial update describes spectroscopy research in children and adolescents with bipolar disorder, with ADHD listed amo…
-
FDA approval · 2013-06-12FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA label_change · 2013-06-11FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC, resulting in cha…
-
FDA approval · 2013-06-11FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR submitted by Sandoz Inc., involving dexmethylphenidate hydrochloride.
-
FDA approval · 2013-06-07FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate submitted by Sandoz Inc.
-
FDA approval · 2013-06-07FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) from Novartis Pharmaceuticals Corporation, signaling an …
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD) [Phase 3]
Phase 3 trial evaluating ADHD in adolescents with substance use disorders has completed. Results were posted in 2013.